January 12, 2016
1 min read
Save

Model using Bauer score, ambulation may predict survival after spine surgery for metastatic disease

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Researchers of this retrospective multicenter study of patients who underwent surgery for spine metastases found 48% survival at 1 year and that a model using a high-modified Bauer score, normal albumin level and intact preoperative ambulatory status was more predictive of survival than use of the modified Bauer score alone.

Researchers attempted to create a model of survival for 307 patients who underwent surgical intervention for metastatic disease involving the spine. Patients had an average age of 60.2 years. Most patients were Caucasian and 58% were male. The most common diagnosis in the patient cohort was lung cancer (16.4%), followed by breast cancer (13.2%). The patients’ demographic, medical, surgical, oncological and survival data were taken from medical records.

The 1-year survival rate was 48%, with a median survival of 10 months for the patient cohort.

Researchers found patients with a high-modified Bauer score, intact preoperative ambulatory status and a normal albumin level had a higher rate of survival than patients who did not.

“Our primary study results demonstrate that patients with a higher-modified Bauer score, intact preoperative ambulatory status, and normal albumin live longer, and these three criteria can be used to model survival,” researchers wrote in the study.

Researchers noted that a patient with a high-modified Bauer score has a 67% chance of survival at 1-year follow-up. However, with no other “healthiness states,” that rate of survival drops to 30%. If that patient has two other “healthiness states,” the rate of survival jumps to 78%.  Researchers concluded their model is capable of predicting outcomes and is easy to use. – by Robert Linnehan

Disclosures: Ghori reports no relevant financial disclosures. Please see the full study for a list of all other authors’ relevant financial disclosures.